Ballooned hepatocytes, undead cells, sonic hedgehog, and Vitamin E: Therapeutic implications for nonalcoholic steatohepatitis

Hepatology

Volumn 61, Issue 1, 2015, Pages 15-17

  Hirsova, Petra ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CASPASE 9; PIOGLITAZONE; PLACEBO; SONIC HEDGEHOG PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UBIQUITINATED PROTEIN; VITAMIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BALLOONED HEPATOCYTE; BASAL CELL CARCINOMA; CELL DEGENERATION; CELL ENLARGEMENT; CELL POPULATION; CORRELATIONAL STUDY; DROSOPHILA MELANOGASTER; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPOTOXICITY; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; LIVER INJURY; NATIONAL HEALTH ORGANIZATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSITIVITY AND SPECIFICITY; SURVIVAL FACTOR; TISSUE REPAIR; FEMALE; MALE; METABOLISM;

FEMALE; HEDGEHOG PROTEINS; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; VITAMIN E; VITAMINS;

EID: 84920982265     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27279     Document Type: Editorial

References (16)

1. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003;125:437-443.
2. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004;99:1708-1717.
3. Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, Diehl AM. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012;55:1711-1721.
4. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
5. Bohinc BN, Diehl AM. Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis 2012;16:549-565.
6. Rangwala F, Guy CD, Lu J, Suzuki A, Burchette JL, Abdelmalek MF, et al. Increased production of sonic hedgehog by ballooned hepatocytes. J Pathol 2011;224:401-410.
7. Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 2008;48:821-828.
8. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell 2011;147:742-758.
9. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nature reviews. Mol Cell Biol 2008;9:231-241.
10. Kakisaka K, Cazanave SC, Werneburg NW, Razumilava N, Mertens JC, Bronk SF, Gores GJ. A hedgehog survival pathway in 'undead' lipotoxic hepatocytes. J Hepatol 2012;57:844-851.
11. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685.
12. Robbins DJ, Fei DL, Riobo NA. The Hedgehog signal transduction network. Sci Signal 2012;5:re6.
13. Guy CD, Suzuki A, Abdelmalek MF, Burchette JL, Diehl AM. Treatment response in the PIVENS trial is associated with decreased hedgehog pathway activity. Hepatology 2015;61:98-107.
14. Bijlsma MF, Damhofer H, Roelink H. Hedgehog-stimulated chemotaxis is mediated by smoothened located outside the primary cilium. Sci Signal 2012;5:ra60.
15. Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 2013;8:e70599.
16. Guha M. Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential. Nature reviews. Drug Discov 2012;11:257-258.